|
Symbol |
Object Name |
Qualifiers
|
Evidence |
Notes |
Source |
PubMed Reference(s) |
RGD Reference(s) |
Position |
|
G
|
Abca8
|
ATP binding cassette subfamily A member 8
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [ABCA8 protein results in increased uptake of estradiol-17 beta-glucuronide]
|
CTD |
PMID:12379217 |
|
NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988
|
|
G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
increases transport multiple interactions decreases activity decreases expression increases activity increases expression affects response to substance
|
ISO EXP
|
ABCB1 protein results in increased transport of Verapamil [Endosulfan co-treated with Verapamil] inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [Endosulfan co-treated with Verapamil] results in decreased activity of ABCB1 protein; [phosalone co-treated with Verapamil] inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [phosalone co-treated with Verapamil] results in decreased activity of ABCB1 protein; [Verapamil binds to and results in decreased activity of ABCB1 protein] inhibits the reaction [sodium arsenite promotes the reaction [ABCB1 protein results in increased secretion of calcein AM]]; [Verapamil binds to and results in decreased activity of ABCB1 protein] which results in decreased export of Digoxin; [Verapamil binds to and results in decreased activity of ABCB1 protein] which results in decreased transport of N-cyano-1-((3,4-dimethoxyphenyl)methyl)-3,4-dihydro-6,7-dimethoxy-N'-octyl-2(1H)-isoquinoline-carboximidamide; [Verapamil co-treated with kaempferol] results in decreased expression of ABCB1 mRNA; [Verapamil co-treated with kaempferol] results in decreased expression of ABCB1 protein; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased export of calcein AM; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased export of Rhodamine 123; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased export of Topotecan; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of benzoylaconine; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of benzoylhypaconine; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of benzoylmesaconine; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of Digoxin; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of hypaconitine; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of mesaconitine; [Verapamil results in decreased activity of ABCB1 protein] which results in increased susceptibility to Doxorubicin; [Verapamil results in decreased activity of ABCB1 protein] which results in increased susceptibility to Paclitaxel; [Verapamil results in decreased activity of ABCB1 protein] which results in increased uptake of fluorexon; Colchicine inhibits the reaction [Verapamil analog results in increased activity of ABCB1 protein mutant form]; Cyclosporine inhibits the reaction [Verapamil analog results in increased activity of ABCB1 protein mutant form]; Demecolcine inhibits the reaction [Verapamil analog results in increased activity of ABCB1 protein mutant form]; Diazinon promotes the reaction [Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [Verapamil results in decreased activity of ABCB1 protein]; Glycyrrhetinic Acid inhibits the reaction [Verapamil results in increased activity of ABCB1 protein]; propiconazole promotes the reaction [Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; propiconazole promotes the reaction [Verapamil results in decreased activity of ABCB1 protein]; Verapamil affects the reaction [ABCB1 protein results in increased export of Tacrolimus]; Verapamil binds to and affects the activity of ABCB1 protein; Verapamil binds to and results in decreased activity of ABCB1 protein; Verapamil inhibits the reaction [5-Methoxypsoralen results in decreased activity of ABCB1 protein]; Verapamil inhibits the reaction [[5-Methoxypsoralen results in decreased activity of ABCB1 protein] which results in decreased export of and results in increased abundance of Daunorubicin]; Verapamil inhibits the reaction [[Methoxsalen results in decreased activity of ABCB1 protein] which results in decreased export of and results in increased abundance of Daunorubicin]; Verapamil inhibits the reaction [ABCB1 protein affects the transport of traumatic acid]; Verapamil inhibits the reaction [ABCB1 protein affects the uptake of Vinblastine]; Verapamil inhibits the reaction [ABCB1 protein results in decreased abundance of Quercetin]; Verapamil inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin]; Verapamil inhibits the reaction [ABCB1 protein results in decreased susceptibility to Paclitaxel]; Verapamil inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; Verapamil inhibits the reaction [ABCB1 protein results in decreased uptake of Doxorubicin]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of calcein AM]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of Doxorubicin]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of Fluorescent Dyes]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of cyazofamid]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Daunorubicin]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Digoxin]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Doxorubicin]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of huperzine A]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of N-cyano-1-((3,4-dimethoxyphenyl)methyl)-3,4-dihydro-6,7-dimethoxy-N'-octyl-2(1H)-isoquinoline-carboximidamide]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Paclitaxel]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of quinidinium]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Sulpiride]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Vinblastine]; Verapamil inhibits the reaction [ABCB1 protein results in increased uptake of Digoxin]; Verapamil inhibits the reaction [Acetaminophen results in increased activity of ABCB1 protein]; Verapamil inhibits the reaction [Doxorubicin results in increased activity of ABCB1 protein]; Verapamil inhibits the reaction [Methoxsalen results in decreased activity of ABCB1 protein]; Verapamil inhibits the reaction [tangeretin results in increased activity of ABCB1 protein]; Verapamil inhibits the reaction [Verapamil analog results in increased activity of ABCB1 protein mutant form]; Verapamil promotes the reaction [ABCB1 protein mutant form binds to 8-azidoadenosine 5'-triphosphate]; Verapamil promotes the reaction [galangin results in increased activity of ABCB1 protein]; Verapamil promotes the reaction [kaempferol results in increased activity of ABCB1 protein]; Verapamil promotes the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Verapamil promotes the reaction [propiconazole results in decreased activity of ABCB1 protein]; Verapamil promotes the reaction [Quercetin results in increased activity of ABCB1 protein]; Vinblastine inhibits the reaction [Verapamil analog results in increased activity of ABCB1 protein mutant form]; yu ping feng san inhibits the reaction [Verapamil results in increased activity of ABCB1 protein] Verapamil results in decreased expression of ABCB1 protein Verapamil analog results in increased activity of ABCB1 protein mutant form; Verapamil results in increased activity of ABCB1 protein Verapamil results in increased expression of ABCB1 mRNA [Verapamil results in decreased expression of ABCB1] promotes the reaction [Doxorubicin results in increased activity of CASP3 protein]; [Verapamil results in decreased expression of ABCB1] promotes the reaction [Doxorubicin results in increased activity of CASP7 protein]; Verapamil promotes the reaction [Vanadates results in decreased activity of ABCB1A protein] [Verapamil results in decreased activity of ABCB1 protein] inhibits the reaction [P-glycoprotein inducer and activator TX5 results in increased export of Rhodamine 123]; Verapamil inhibits the reaction [ABCB1 results in decreased susceptibility to Cadmium Chloride] ABCB1A protein affects the susceptibility to Verapamil Verapamil results in decreased activity of ABCB1A protein Verapamil results in decreased activity of ABCB1 protein; Verapamil results in decreased activity of ABCB1A protein Verapamil results in decreased expression of ABCB1A mRNA
|
CTD |
PMID:2900677 PMID:7083125 PMID:7476894 PMID:8917702 PMID:10527640 PMID:10571255 PMID:10636889 PMID:10997946 PMID:11027628 PMID:11836167 PMID:11895100 PMID:11920757 PMID:12202523 PMID:12387747 PMID:12670938 PMID:12708479 PMID:12711602 PMID:15112361 PMID:15276086 PMID:15451006 PMID:15502009 PMID:15627040 PMID:15640379 PMID:15725475 PMID:15861398 PMID:16033948 PMID:16049968 PMID:16121039 PMID:16442095 PMID:16904803 PMID:16930294 PMID:16959878 PMID:17134887 PMID:17526808 PMID:17947497 PMID:17973928 PMID:18204840 PMID:18408562 PMID:18673531 PMID:19070657 PMID:19505989 PMID:19528478 PMID:19944135 PMID:20457140 PMID:21783720 PMID:22079615 PMID:22233293 PMID:23200901 PMID:23273999 PMID:23976943 PMID:24321342 PMID:24380838 PMID:24446304 PMID:25058526 PMID:25268938 PMID:25625052 PMID:26995013 PMID:28587984 PMID:28597291 PMID:28669723 PMID:29079042 PMID:29174985 PMID:29625142 PMID:30102254 PMID:30391378 PMID:31348918 PMID:31756430 PMID:32003934 PMID:32497533 PMID:33321149 PMID:34135758 PMID:34217736 PMID:35063459 PMID:35550413 PMID:35753429 PMID:37259354 PMID:37985955 PMID:38367674 PMID:39041788 More...
|
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G
|
Abcb1b
|
ATP-binding cassette, sub-family B member 1B
|
decreases activity affects response to substance
|
EXP ISO
|
Verapamil results in decreased activity of ABCB1B protein ABCB1B protein affects the susceptibility to Verapamil
|
CTD |
PMID:12202523 PMID:15502009 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G
|
Abcb4
|
ATP binding cassette subfamily B member 4
|
decreases activity decreases expression
|
EXP ISO
|
Verapamil results in decreased activity of ABCB4 protein Verapamil results in decreased expression of ABCB4 mRNA
|
CTD |
PMID:12202523 PMID:28437613 PMID:28552422 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G
|
Abcc1
|
ATP binding cassette subfamily C member 1
|
affects activity multiple interactions decreases activity
|
ISO
|
Verapamil affects the activity of ABCC1 protein Verapamil inhibits the reaction [ABCC1 protein affects the export of 5-carboxyfluorescein diacetate]; Verapamil inhibits the reaction [ABCC1 protein affects the export of Daunorubicin]; Verapamil inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin]; Verapamil inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; Verapamil inhibits the reaction [ABCC1 protein results in increased export of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein]; Verapamil promotes the reaction [ABCC1 protein affects the export of Glutathione]; Verapamil promotes the reaction [ABCC1 protein affects the transport of Glutathione]; Verapamil promotes the reaction [ABCC1 protein results in increased uptake of Glutathione] Verapamil results in decreased activity of ABCC1 protein Verapamil inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide]; Verapamil inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin]; Verapamil inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide]
|
CTD |
PMID:7954421 PMID:9334814 PMID:10856430 PMID:11278867 PMID:12485947 PMID:15044619 PMID:15451006 PMID:15498506 PMID:16101123 PMID:16636798 More...
|
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [ABCC2 protein affects the export of 5-carboxyfluorescein diacetate]
|
CTD |
PMID:16636798 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G
|
Abcc3
|
ATP binding cassette subfamily C member 3
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [ABCC3 protein affects the export of 5-carboxyfluorescein diacetate]
|
CTD |
PMID:16636798 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G
|
Abcc6
|
ATP binding cassette subfamily C member 6
|
decreases activity
|
ISO
|
Verapamil results in decreased activity of ABCC6 protein
|
CTD |
PMID:14667841 |
|
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
|
|
G
|
Acta2
|
actin alpha 2, smooth muscle
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [[Carbon Tetrachloride co-treated with lard co-treated with Ethanol] results in increased expression of ACTA2 protein]
|
CTD |
PMID:17223571 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G
|
Adra1a
|
adrenoceptor alpha 1A
|
multiple interactions affects binding
|
ISO
|
[Quinidine co-treated with Verapamil] inhibits the reaction [ADRA1A protein results in increased abundance of Inositol 1,4,5-Trisphosphate]; Verapamil inhibits the reaction [ADRA1A protein results in increased abundance of Inositol 1,4,5-Trisphosphate] Verapamil binds to ADRA1A protein
|
CTD |
PMID:9570190 |
|
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G
|
Adra1b
|
adrenoceptor alpha 1B
|
affects binding multiple interactions
|
ISO
|
Verapamil binds to ADRA1B protein [Quinidine co-treated with Verapamil] inhibits the reaction [ADRA1B protein results in increased abundance of Inositol 1,4,5-Trisphosphate]; Verapamil inhibits the reaction [ADRA1B protein results in increased abundance of Inositol 1,4,5-Trisphosphate]
|
CTD |
PMID:9570190 |
|
NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,255,025...28,312,919
|
|
G
|
Adra1d
|
adrenoceptor alpha 1D
|
multiple interactions affects binding
|
ISO
|
[Quinidine co-treated with Verapamil] inhibits the reaction [ADRA1D protein results in increased abundance of Inositol 1,4,5-Trisphosphate]; Verapamil inhibits the reaction [ADRA1D protein results in increased abundance of Inositol 1,4,5-Trisphosphate] Verapamil binds to ADRA1D protein
|
CTD |
PMID:9570190 |
|
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
|
|
G
|
Adrb1
|
adrenoceptor beta 1
|
affects response to substance
|
ISO
|
ADRB1 protein polymorphism affects the susceptibility to Verapamil
|
CTD |
PMID:22192668 |
|
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:255,771,597...255,807,259
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Thioacetamide results in decreased expression of AKT1 mRNA]
|
CTD |
PMID:30526075 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G
|
Aqp1
|
aquaporin 1
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [cobaltous chloride results in increased expression of AQP1 protein]
|
CTD |
PMID:22415096 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
ISO
|
Verapamil results in increased expression of BAX protein [Verapamil co-treated with Temozolomide] results in increased expression of BAX mRNA; Temozolomide promotes the reaction [Verapamil results in increased expression of BAX protein]
|
CTD |
PMID:30003979 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions decreases expression
|
ISO
|
[Temozolomide co-treated with Verapamil] results in decreased expression of BCL2 mRNA; [Temozolomide co-treated with Verapamil] results in decreased expression of BCL2 protein; [Verapamil co-treated with gambogic acid] results in decreased expression of BCL2 protein Verapamil results in decreased expression of BCL2 mRNA; Verapamil results in decreased expression of BCL2 protein
|
CTD |
PMID:24373880 PMID:30003979 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G
|
Cacna1c
|
calcium voltage-gated channel subunit alpha1 C
|
increases response to substance multiple interactions decreases expression
|
ISO EXP
|
CACNA1C gene polymorphism results in increased susceptibility to Verapamil Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1C mRNA]; Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1C protein] Verapamil results in decreased expression of CACNA1C mRNA; Verapamil results in decreased expression of CACNA1C protein Verapamil inhibits the reaction [Iron-Dextran Complex affects the expression of CACNA1C protein]
|
CTD |
PMID:19791473 PMID:20031608 PMID:27095094 |
|
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G
|
Cacna1f
|
calcium voltage-gated channel subunit alpha1 F
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [CACNA1F protein results in increased transport of Barium]
|
CTD |
PMID:14744918 |
|
NCBI chr X:14,868,096...14,896,413
Ensembl chr X:14,868,024...14,896,413
|
|
G
|
Cacna1h
|
calcium voltage-gated channel subunit alpha1 H
|
multiple interactions decreases expression
|
EXP
|
Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1H mRNA]; Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1H protein] Verapamil results in decreased expression of CACNA1H mRNA; Verapamil results in decreased expression of CACNA1H protein
|
CTD |
PMID:19791473 |
|
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
|
|
G
|
Calca
|
calcitonin-related polypeptide alpha
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [[Ionomycin co-treated with Lipopolysaccharides] results in increased expression of CALCA protein]; Verapamil inhibits the reaction [Lipopolysaccharides results in increased expression of CALCA mRNA]
|
CTD |
PMID:20682585 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G
|
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [LIF protein results in increased activity of CAMK2A protein]; Verapamil inhibits the reaction [LIF protein results in increased phosphorylation of CAMK2A protein]
|
CTD |
PMID:11073891 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G
|
Camk4
|
calcium/calmodulin-dependent protein kinase IV
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [LIF protein results in increased activity of CAMK4 protein]
|
CTD |
PMID:11073891 |
|
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487
|
|
G
|
Casp1
|
caspase 1
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [7-ketocholesterol results in increased activity of CASP1 protein]; Verapamil inhibits the reaction [Cholesterol analog results in increased activity of CASP1 protein]
|
CTD |
PMID:28633109 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G
|
Casp12
|
caspase 12
|
multiple interactions
|
ISO
|
[Verapamil co-treated with Ruthenium Red co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Trichlorfon results in increased cleavage of and results in increased activity of CASP12 protein]
|
CTD |
PMID:19631781 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions increases expression
|
ISO EXP
|
[Doxorubicin co-treated with Verapamil] results in increased activity of CASP3 protein; [Verapamil co-treated with gambogic acid] results in increased cleavage of and results in increased activity of CASP3 protein; [Verapamil co-treated with Ruthenium Red co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Trichlorfon results in increased cleavage of and results in increased activity of CASP3 protein]; Verapamil inhibits the reaction [Pilocarpine results in increased activity of CASP3 protein] [Verapamil results in decreased expression of ABCB1] promotes the reaction [Doxorubicin results in increased activity of CASP3 protein] Verapamil inhibits the reaction [Simvastatin results in increased activity of CASP3 protein] Verapamil results in increased expression of CASP3 mRNA
|
CTD |
PMID:14527821 PMID:15861398 PMID:18358092 PMID:19631781 PMID:19815060 PMID:19927300 PMID:24373880 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G
|
Casp7
|
caspase 7
|
multiple interactions
|
ISO
|
[Verapamil results in decreased expression of ABCB1] promotes the reaction [Doxorubicin results in increased activity of CASP7 protein]
|
CTD |
PMID:15861398 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G
|
Casp8
|
caspase 8
|
multiple interactions
|
ISO
|
[Verapamil co-treated with gambogic acid] results in increased cleavage of and results in increased activity of CASP8 protein
|
CTD |
PMID:24373880 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions
|
ISO
|
[Verapamil co-treated with gambogic acid] results in increased cleavage of and results in increased activity of CASP9 protein
|
CTD |
PMID:24373880 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G
|
Cd44
|
CD44 molecule
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [CD44 protein binds to Hyaluronic Acid]]; Verapamil inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of CD44 protein] [Verapamil co-treated with kaempferol] results in decreased expression of CD44 mRNA; [Verapamil co-treated with kaempferol] results in decreased expression of CD44 protein
|
CTD |
PMID:9929743 PMID:35063459 |
|
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:89,157,058...89,244,620
|
|
G
|
Cdh1
|
cadherin 1
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]
|
CTD |
PMID:34217686 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G
|
Ciita
|
class II, major histocompatibility complex, transactivator
|
affects expression
|
ISO
|
Verapamil affects the expression of CIITA mRNA
|
CTD |
PMID:25811541 |
|
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
|
|
G
|
Clu
|
clusterin
|
affects expression
|
ISO
|
Verapamil affects the expression of CLU protein
|
CTD |
PMID:12388792 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G
|
Col1a1
|
collagen type I alpha 1 chain
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [Iron-Dextran Complex results in increased expression of COL1A1 protein] Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]
|
CTD |
PMID:27095094 PMID:34217686 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G
|
Col3a1
|
collagen type III alpha 1 chain
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 protein]
|
CTD |
PMID:34217686 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G
|
Csrp3
|
cysteine and glycine rich protein 3
|
decreases localization
|
EXP
|
Verapamil results in decreased localization of CSRP3 protein
|
CTD |
PMID:19376126 |
|
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
|
|
G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
decreases activity
|
ISO
|
Verapamil results in decreased activity of CYP1A1 protein
|
CTD |
PMID:18420780 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
decreases activity
|
ISO
|
Verapamil results in decreased activity of CYP1A2 protein
|
CTD |
PMID:18420780 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
|
|
G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
decreases activity
|
ISO
|
Verapamil results in decreased activity of CYP1B1 protein
|
CTD |
PMID:18420780 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G
|
Cyp2a3
|
cytochrome P450, family 2, subfamily a, polypeptide 3
|
decreases activity
|
ISO
|
Verapamil results in decreased activity of CYP2A4 protein
|
CTD |
PMID:18420780 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
decreases activity
|
ISO
|
Verapamil results in decreased activity of CYP2B10 protein
|
CTD |
PMID:18420780 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G
|
Cyp2c11
|
cytochrome P450, subfamily 2, polypeptide 11
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Cyclosporine results in increased expression of CYP2C11 protein]
|
CTD |
PMID:28899749 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
decreases activity
|
ISO
|
Verapamil results in decreased activity of CYP2C29 protein
|
CTD |
PMID:18420780 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G
|
Cyp2c79
|
cytochrome P450, family 2, subfamily c, polypeptide 79
|
multiple interactions decreases activity
|
ISO
|
torsemide inhibits the reaction [Verapamil results in decreased activity of CYP2C8 protein]
|
CTD |
PMID:15304522 |
|
|
|
G
|
Cyp2d4
|
cytochrome P450, family 2, subfamily d, polypeptide 4
|
decreases activity
|
ISO
|
Verapamil results in decreased activity of CYP2D22 protein; Verapamil results in decreased activity of CYP2D6 protein
|
CTD |
PMID:18420780 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G
|
Cyp3a18
|
cytochrome P450, family 3, subfamily a, polypeptide 18
|
decreases expression
|
EXP
|
Verapamil results in decreased expression of CYP3A18 mRNA
|
CTD |
PMID:17973928 |
|
NCBI chr12:8,880,509...8,930,382
Ensembl chr12:8,880,528...8,930,381
|
|
G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
decreases activity multiple interactions affects metabolic processing
|
ISO
|
Verapamil results in decreased activity of CYP3A4 protein [Verapamil results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; naringin inhibits the reaction [CYP3A4 protein affects the metabolism of Verapamil]; Verapamil inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Verapamil inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone]; Verapamil inhibits the reaction [CYP3A4 protein results in increased metabolism of Midazolam]; Verapamil inhibits the reaction [CYP3A4 protein results in increased metabolism of Testosterone]; Verapamil inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin]
|
CTD |
PMID:15286053 PMID:15689501 PMID:15692829 PMID:15860655 PMID:16013069 PMID:19299527 PMID:21915887 PMID:25455453 PMID:39023798 More...
|
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9
|
decreases activity decreases expression
|
ISO EXP
|
Verapamil results in decreased activity of CYP3A5 protein Verapamil results in decreased expression of CYP3A9 mRNA
|
CTD |
PMID:15689501 PMID:17973928 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions
|
ISO
|
[Verapamil co-treated with gambogic acid] results in increased expression of DDIT3 protein
|
CTD |
PMID:24373880 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G
|
Dnm1l
|
dynamin 1-like
|
multiple interactions increases phosphorylation
|
ISO
|
Verapamil inhibits the reaction [bisphenol A affects the localization of DNM1L protein] Verapamil results in increased phosphorylation of DNM1L protein
|
CTD |
PMID:31830493 PMID:34023961 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G
|
Drd1
|
dopamine receptor D1
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [SCH 23390 binds to DRD1 protein]
|
CTD |
PMID:9533112 |
|
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
|
|
G
|
Drd2
|
dopamine receptor D2
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [Raclopride binds to DRD2 protein]
|
CTD |
PMID:9533112 |
|
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G
|
Edn1
|
endothelin 1
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [EDN1 protein results in increased expression of NPPB mRNA]; Verapamil inhibits the reaction [EDN1 protein results in increased expression of NPPB protein]
|
CTD |
PMID:28942281 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G
|
Fn1
|
fibronectin 1
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]
|
CTD |
PMID:34217686 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
ISO
|
Verapamil results in increased expression of FOS mRNA
|
CTD |
PMID:12730611 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G
|
Fth1
|
ferritin heavy chain 1
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [Iron-Dextran Complex results in increased expression of FTH1 protein]
|
CTD |
PMID:27095094 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G
|
Gal
|
galanin and GMAP prepropeptide
|
affects expression
|
ISO
|
Verapamil affects the expression of GAL protein
|
CTD |
PMID:12388792 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G
|
Gap43
|
growth associated protein 43
|
affects expression
|
ISO
|
Verapamil affects the expression of GAP43 protein
|
CTD |
PMID:12388792 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G
|
Gata4
|
GATA binding protein 4
|
multiple interactions
|
ISO
|
Verapamil promotes the reaction [Diethylhexyl Phthalate results in decreased expression of GATA4 mRNA]; Verapamil promotes the reaction [Diethylhexyl Phthalate results in decreased expression of GATA4 protein]
|
CTD |
PMID:31086358 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G
|
Gc
|
GC, vitamin D binding protein
|
affects expression
|
EXP
|
Verapamil affects the expression of GC protein
|
CTD |
PMID:23533533 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G
|
Gfap
|
glial fibrillary acidic protein
|
multiple interactions increases expression
|
EXP
|
Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein]; Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] Verapamil results in increased expression of GFAP mRNA
|
CTD |
PMID:21863293 PMID:21879721 PMID:22954530 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Thioacetamide results in increased expression of GPT protein]
|
CTD |
PMID:30526075 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G
|
Gsn
|
gelsolin
|
affects expression
|
EXP
|
Verapamil affects the expression of GSN protein
|
CTD |
PMID:23533533 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G
|
Hamp
|
hepcidin antimicrobial peptide
|
multiple interactions
|
ISO
|
Verapamil promotes the reaction [Iron-Dextran Complex results in increased expression of HAMP mRNA]
|
CTD |
PMID:27095094 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G
|
Hey2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
multiple interactions
|
ISO
|
Verapamil promotes the reaction [Diethylhexyl Phthalate results in decreased expression of HEY2 mRNA]; Verapamil promotes the reaction [Diethylhexyl Phthalate results in decreased expression of HEY2 protein]; Verapamil promotes the reaction [Diethylhexyl Phthalate results in increased expression of HEY2 mRNA]
|
CTD |
PMID:31086358 |
|
NCBI chr 1:26,822,131...26,832,218
Ensembl chr 1:26,822,131...26,832,218
|
|
G
|
Hmox1
|
heme oxygenase 1
|
increases expression multiple interactions
|
ISO EXP
|
Verapamil results in increased expression of HMOX1 protein Verapamil inhibits the reaction [Thioacetamide results in decreased expression of HMOX1 mRNA]
|
CTD |
PMID:21525764 PMID:30526075 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G
|
Iapp
|
islet amyloid polypeptide
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Glucose results in increased expression of IAPP mRNA]
|
CTD |
PMID:9142872 |
|
NCBI chr 4:175,237,107...175,244,373
Ensembl chr 4:175,237,115...175,242,920
|
|
G
|
Il1a
|
interleukin 1 alpha
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [Particulate Matter results in increased expression of IL1A mRNA]
|
CTD |
PMID:15613243 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO EXP
|
Verapamil inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased secretion of IL6 protein]
|
CTD |
PMID:20682585 PMID:35460826 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G
|
Insr
|
insulin receptor
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of INSR mRNA]; Verapamil inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of INSR protein]
|
CTD |
PMID:35460826 |
|
NCBI chr12:5,991,135...6,129,275
Ensembl chr12:1,197,100...1,330,883
|
|
G
|
Kcna10
|
potassium voltage-gated channel subfamily A member 10
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [KCNA10 protein results in increased transport of Potassium]
|
CTD |
PMID:10836990 |
|
NCBI chr 2:194,786,500...194,798,575
Ensembl chr 2:194,786,500...194,798,575
|
|
G
|
Kcna3
|
potassium voltage-gated channel subfamily A member 3
|
decreases activity multiple interactions
|
ISO
|
Verapamil results in decreased activity of KCNA3 protein [Verapamil results in decreased activity of KCNA3 protein] which results in decreased import of Thallium
|
CTD |
PMID:21362439 |
|
NCBI chr 2:194,632,106...194,634,059
Ensembl chr 2:194,632,196...194,650,138
|
|
G
|
Kcnd3
|
potassium voltage-gated channel subfamily D member 3
|
decreases activity
|
ISO
|
Verapamil results in decreased activity of KCND3 protein
|
CTD |
PMID:11181069 |
|
NCBI chr 2:192,937,950...193,155,345
Ensembl chr 2:192,937,950...193,155,345
|
|
G
|
Kcnh2
|
potassium voltage-gated channel subfamily H member 2
|
multiple interactions decreases activity
|
ISO
|
[Verapamil results in decreased activity of KCNH2 protein] which results in decreased import of Thallium; Verapamil inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
|
CTD |
PMID:15671647 PMID:19583963 PMID:21158687 PMID:21362439 PMID:24052561 PMID:30561737 More...
|
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G
|
Kcnmb1
|
potassium calcium-activated channel subfamily M regulatory beta subunit 1
|
affects response to substance
|
ISO
|
KCNMB1 gene SNP affects the susceptibility to Verapamil
|
CTD |
PMID:17700361 |
|
NCBI chr10:18,557,510...18,614,824
Ensembl chr10:18,557,904...18,565,798
|
|
G
|
Lif
|
LIF, interleukin 6 family cytokine
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [LIF protein results in increased activity of CAMK2A protein]; Verapamil inhibits the reaction [LIF protein results in increased activity of CAMK4 protein]; Verapamil inhibits the reaction [LIF protein results in increased phosphorylation of CAMK2A protein]
|
CTD |
PMID:11073891 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:15456914 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:15456914 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Gentamicins results in increased phosphorylation of and results in increased activity of MAPK8 protein]
|
CTD |
PMID:15936777 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G
|
Mef2c
|
myocyte enhancer factor 2C
|
multiple interactions
|
ISO
|
Verapamil promotes the reaction [Diethylhexyl Phthalate results in decreased expression of MEF2C mRNA]; Verapamil promotes the reaction [Diethylhexyl Phthalate results in decreased expression of MEF2C protein]
|
CTD |
PMID:31086358 |
|
NCBI chr 2:13,973,299...14,136,065
Ensembl chr 2:13,993,438...14,132,880
|
|
G
|
Mmp13
|
matrix metallopeptidase 13
|
multiple interactions
|
EXP
|
Verapamil promotes the reaction [ferrous sulfate results in increased expression of MMP13 protein]
|
CTD |
PMID:27095094 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G
|
Mpo
|
myeloperoxidase
|
multiple interactions
|
EXP
|
Verapamil promotes the reaction [Paraquat results in increased activity of MPO protein]
|
CTD |
PMID:17015168 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G
|
Mtor
|
mechanistic target of rapamycin kinase
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of MTOR mRNA]; Verapamil inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of MTOR protein]
|
CTD |
PMID:35460826 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
|
|
G
|
Mybpc3
|
myosin binding protein C3
|
affects response to substance
|
ISO
|
MYBPC3 protein affects the susceptibility to Verapamil
|
CTD |
PMID:23896226 |
|
NCBI chr 3:77,095,165...77,113,406
Ensembl chr 3:77,095,252...77,113,405
|
|
G
|
Myh7
|
myosin heavy chain 7
|
multiple interactions decreases expression
|
ISO
|
Dexamethasone inhibits the reaction [Verapamil results in decreased expression of MYH7 mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Verapamil results in decreased expression of MYH7 mRNA]]
|
CTD |
PMID:19596060 |
|
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
|
|
G
|
Myl2
|
myosin light chain 2
|
multiple interactions decreases expression
|
ISO
|
[Verapamil co-treated with Doxorubicin] results in decreased expression of MYL2 mRNA; Dexamethasone inhibits the reaction [[Verapamil co-treated with Doxorubicin] results in decreased expression of MYL2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [[Verapamil co-treated with Doxorubicin] results in decreased expression of MYL2 mRNA]] Verapamil results in decreased expression of MYL2 mRNA
|
CTD |
PMID:19596060 |
|
NCBI chr12:34,454,223...34,468,554
Ensembl chr12:34,454,218...34,468,983
|
|
G
|
Nanog
|
Nanog homeobox
|
multiple interactions
|
ISO
|
[Verapamil co-treated with kaempferol] results in decreased expression of NANOG mRNA; [Verapamil co-treated with kaempferol] results in decreased expression of NANOG protein
|
CTD |
PMID:35063459 |
|
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
|
|
G
|
Nefl
|
neurofilament light chain
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein]; Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein]
|
CTD |
PMID:21863293 PMID:21879721 |
|
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G
|
Nefm
|
neurofilament medium chain
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFM protein]; Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFM protein]
|
CTD |
PMID:21863293 PMID:21879721 |
|
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
affects localization multiple interactions
|
ISO EXP
|
Verapamil affects the localization of NFE2L2 protein Verapamil inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 mRNA]; Verapamil inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 protein]; Verapamil promotes the reaction [Cilostazol inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 protein]]
|
CTD |
PMID:21525764 PMID:30295103 PMID:30526075 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NLRP3 mRNA]; Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NLRP3 protein]
|
CTD |
PMID:35460826 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G
|
Nppa
|
natriuretic peptide A
|
multiple interactions affects secretion increases expression
|
ISO
|
[Cilazapril co-treated with Verapamil] affects the secretion of NPPA protein Verapamil affects the secretion of NPPA protein Verapamil results in increased expression of NPPA protein
|
CTD |
PMID:1457087 PMID:11996326 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G
|
Nppb
|
natriuretic peptide B
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [EDN1 protein results in increased expression of NPPB mRNA]; Verapamil inhibits the reaction [EDN1 protein results in increased expression of NPPB protein]
|
CTD |
PMID:28942281 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Thioacetamide results in decreased expression of NQO1 protein]; Verapamil promotes the reaction [Cilostazol inhibits the reaction [Thioacetamide results in decreased expression of NQO1 protein]]
|
CTD |
PMID:30295103 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G
|
Nr0b1
|
nuclear receptor subfamily 0, group B, member 1
|
multiple interactions decreases expression
|
ISO
|
Verapamil promotes the reaction [Cyclic AMP results in decreased expression of NR0B1 mRNA] Verapamil results in decreased expression of NR0B1 mRNA
|
CTD |
PMID:19822634 |
|
NCBI chr X:50,756,886...50,761,014
Ensembl chr X:50,756,886...50,761,011
|
|
G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
increases activity multiple interactions
|
ISO
|
Verapamil results in increased activity of NR1I2 protein [Verapamil results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA
|
CTD |
PMID:25455453 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1
|
multiple interactions
|
ISO
|
Verapamil promotes the reaction [Dexamethasone results in increased activity of NR3C1 protein]
|
CTD |
PMID:12871829 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [PARP1 gene mutant form results in decreased uptake of Doxorubicin] [Verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[Verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[Verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein]
|
CTD |
PMID:15861398 PMID:24373880 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G
|
Pf4
|
platelet factor 4
|
decreases expression
|
ISO
|
Verapamil results in decreased expression of PF4 protein
|
CTD |
PMID:2962587 |
|
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
|
|
G
|
Polr1h
|
RNA polymerase I subunit H
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Doxorubicin]; Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Etoposide]; Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Vincristine]; Verapamil inhibits the reaction [POLR1H protein results in increased secretion of Doxorubicin]
|
CTD |
PMID:14726695 |
|
NCBI chr20:1,594,936...1,598,854
Ensembl chr20:1,594,936...1,598,854
|
|
G
|
Pou5f1
|
POU class 5 homeobox 1
|
multiple interactions
|
ISO
|
[Verapamil co-treated with kaempferol] results in decreased expression of POU5F1 mRNA; [Verapamil co-treated with kaempferol] results in decreased expression of POU5F1 protein
|
CTD |
PMID:35063459 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G
|
Ppbp
|
pro-platelet basic protein
|
decreases expression
|
ISO
|
Verapamil results in decreased expression of PPBP protein
|
CTD |
PMID:2962587 |
|
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
|
|
G
|
Ppp3cb
|
protein phosphatase 3 catalytic subunit beta
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [bisphenol F results in increased expression of PPP3CB protein]
|
CTD |
PMID:34023961 |
|
NCBI chr15:3,759,950...3,804,976
Ensembl chr15:3,760,030...3,804,981
|
|
G
|
Prl
|
prolactin
|
multiple interactions increases expression increases secretion
|
ISO
|
Verapamil inhibits the reaction [Sulpiride results in increased secretion of PRL protein]; Verapamil promotes the reaction [TRH protein results in increased secretion of PRL protein] Verapamil results in increased expression of PRL protein Verapamil results in increased secretion of PRL protein
|
CTD |
PMID:7851873 PMID:8845563 PMID:8977754 PMID:20595935 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G
|
Ret
|
ret proto-oncogene
|
affects expression
|
ISO
|
Verapamil affects the expression of RET protein
|
CTD |
PMID:12388792 |
|
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
|
|
G
|
Slc11a2
|
solute carrier family 11 member 2
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [Iron-Dextran Complex results in increased expression of SLC11A2 protein]
|
CTD |
PMID:27095094 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G
|
Slc19a3
|
solute carrier family 19 member 3
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [SLC19A3 protein results in increased uptake of Metformin]; Verapamil inhibits the reaction [SLC19A3 protein results in increased uptake of Thiamine]
|
CTD |
PMID:26528626 |
|
NCBI chr 9:84,275,722...84,299,368
Ensembl chr 9:84,277,024...84,299,337
|
|
G
|
Slc22a1
|
solute carrier family 22 member 1
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [SLC22A1 protein results in increased import of Tetraethylammonium]; Verapamil inhibits the reaction [SLC22A1 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Verapamil inhibits the reaction [SLC22A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Verapamil inhibits the reaction [SLC22A1 protein results in increased uptake of Tetraethylammonium]
|
CTD |
PMID:21641380 PMID:25466967 PMID:25862123 PMID:27450509 PMID:27989701 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G
|
Slc22a2
|
solute carrier family 22 member 2
|
multiple interactions
|
ISO EXP
|
Verapamil inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] Verapamil inhibits the reaction [SLC22A2 protein results in increased uptake of mepiquat]
|
CTD |
PMID:21599003 PMID:33639197 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G
|
Slc22a3
|
solute carrier family 22 member 3
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Verapamil inhibits the reaction [SLC22A3 protein results in increased uptake of Metformin]
|
CTD |
PMID:21641380 PMID:21697722 |
|
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
|
|
G
|
Slc22a4
|
solute carrier family 22 member 4
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [SLC22A4 protein results in increased uptake of Tetraethylammonium]
|
CTD |
PMID:21641380 |
|
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
|
|
G
|
Slc22a5
|
solute carrier family 22 member 5
|
decreases activity
|
ISO
|
Verapamil results in decreased activity of SLC22A5 protein
|
CTD |
PMID:15486076 |
|
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
|
|
G
|
Slc2a4
|
solute carrier family 2 member 4
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SLC2A4 mRNA]; Verapamil inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SLC2A4 protein]
|
CTD |
PMID:35460826 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G
|
Slc47a1
|
solute carrier family 47 member 1
|
multiple interactions decreases activity
|
ISO
|
Verapamil inhibits the reaction [SLC47A1 protein results in increased import of Tetraethylammonium]; Verapamil inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Verapamil inhibits the reaction [SLC47A1 protein results in increased uptake of Tetraethylammonium] Verapamil results in decreased activity of SLC47A1 protein
|
CTD |
PMID:22419765 PMID:27450509 PMID:27989701 PMID:31364238 |
|
NCBI chr10:46,034,115...46,088,617
Ensembl chr10:46,034,122...46,087,637
|
|
G
|
Slc47a2
|
solute carrier family 47 member 2
|
multiple interactions decreases activity
|
ISO
|
Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of Tetraethylammonium] Verapamil results in decreased activity of SLC47A2 protein
|
CTD |
PMID:22419765 PMID:27989701 PMID:28629854 PMID:31364238 |
|
NCBI chr10:45,990,806...46,033,937
Ensembl chr10:45,991,095...46,033,904
|
|
G
|
Slco1a4
|
solute carrier organic anion transporter family, member 1a4
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [SLCO1A2 protein results in increased uptake of Quercetin]
|
CTD |
PMID:24947867 |
|
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
|
|
G
|
Smad2
|
SMAD family member 2
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]
|
CTD |
PMID:34217686 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions
|
EXP
|
[Verapamil co-treated with Cilostazol] inhibits the reaction [Thioacetamide results in decreased activity of SOD1 protein]; Verapamil inhibits the reaction [Dexamethasone inhibits the reaction [Paraquat results in increased activity of SOD1 protein]]; Verapamil inhibits the reaction [Thioacetamide results in decreased activity of SOD1 protein]
|
CTD |
PMID:17015168 PMID:30295103 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Dexamethasone inhibits the reaction [Paraquat results in increased activity of SOD2 protein]]
|
CTD |
PMID:17015168 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G
|
Sox2
|
SRY-box transcription factor 2
|
multiple interactions
|
ISO
|
[Verapamil co-treated with kaempferol] results in decreased expression of SOX2 mRNA
|
CTD |
PMID:35063459 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G
|
Star
|
steroidogenic acute regulatory protein
|
multiple interactions
|
ISO
|
[Cyclic AMP co-treated with Verapamil] results in increased expression of STAR protein; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Cyclic AMP co-treated with Verapamil] results in increased expression of STAR protein]; N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Cyclic AMP co-treated with Verapamil] results in increased expression of STAR protein]; Verapamil promotes the reaction [Cyclic AMP results in increased expression of STAR mRNA]; Verapamil promotes the reaction [Cyclic AMP results in increased expression of STAR protein]
|
CTD |
PMID:19822634 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased expression of STAT3 protein]; Verapamil inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased expression of STAT3 protein]
|
CTD |
PMID:19299911 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
EXP ISO
|
Verapamil inhibits the reaction [[Carbon Tetrachloride co-treated with lard co-treated with Ethanol] results in increased expression of TGFB1 protein] Verapamil inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 protein]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]; Verapamil inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]; Verapamil inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]
|
CTD |
PMID:17223571 PMID:34217686 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
affects expression multiple interactions
|
ISO EXP
|
Verapamil affects the expression of TIMP1 protein Verapamil inhibits the reaction [ferrous sulfate results in increased expression of TIMP1 protein]
|
CTD |
PMID:12388792 PMID:27095094 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO EXP
|
Verapamil affects the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Verapamil inhibits the reaction [Particulate Matter results in increased secretion of TNF protein] Verapamil inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein] Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased secretion of TNF protein]
|
CTD |
PMID:15613243 PMID:17092623 PMID:17129690 PMID:17369293 PMID:35460826 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G
|
Trh
|
thyrotropin releasing hormone
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [TRH protein results in increased secretion of TSHB protein]; Verapamil promotes the reaction [TRH protein results in increased secretion of PRL protein]
|
CTD |
PMID:7851873 |
|
NCBI chr 4:124,742,111...124,777,094
Ensembl chr 4:124,742,111...124,744,637
|
|
G
|
Tshb
|
thyroid stimulating hormone subunit beta
|
multiple interactions
|
ISO
|
Verapamil inhibits the reaction [TRH protein results in increased secretion of TSHB protein]
|
CTD |
PMID:7851873 |
|
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
|
|
G
|
Txnip
|
thioredoxin interacting protein
|
multiple interactions
|
EXP
|
Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TXNIP mRNA]; Verapamil inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TXNIP protein]
|
CTD |
PMID:35460826 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G
|
Vim
|
vimentin
|
multiple interactions
|
EXP ISO
|
Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of VIM protein]; Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of VIM protein] Verapamil inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]
|
CTD |
PMID:21863293 PMID:21879721 PMID:34217686 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|